CoChat

Intracellular trafficking of TREM2 is regulated by presenilin 1

Open access
Zhao, Yingjun, Li, Xiaoguang, Huang, Timothy, Jiang, Lu-lin, Tan, Zhenqiu, Zhang, Muxian, Cheng, Irene Han-Juo, Wang, Xin, Bu, Guojun, Zhang, Yun-wu, Wang, Qi, Xu, Huaxi · 2017 · Experimental & Molecular Medicine
Cited by 26

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

Genetic mutations in triggering receptor expressed on myeloid cells 2 (TREM2) have been linked to a variety of neurodegenerative diseases including Alzheimer’s disease, amyotrophic lateral sclerosis, frontotemporal dementia and Parkinson’s disease. In the brain, TREM2 is highly expressed on the cell surface of microglia, where it can transduce signals to regulate microglial functions such as phagocytosis. To date, mechanisms underlying intracellular trafficking of TREM2 remain elusive. Mutations in the presenilin 1 (PS1) catalytic subunit of the γ-secretase complex have been associated with increased generation of the amyloidogenic Aβ (amyloid-β) 42 peptide through cleavage of the Aβ precursor amyloid precursor protein. Here we found that TREM2 interacts with PS1 in a manner independent of γ-secretase activity. Mutations in TREM2 alter its subcellular localization and affects its interaction with PS1. Upregulation of PS1 reduces, whereas downregulation of PS1 increases, steady-state levels of cell surface TREM2. Furthermore, PS1 overexpression results in attenuated phagocytic uptake of Aβ by microglia, which is reversed by TREM2 overexpression. Our data indicate a novel role for PS1 in regulating TREM2 intracellular trafficking and pathophysiological function. Researchers have identified a new interaction between two molecules that may clarify development of some neurodegenerative diseases. The TREM2 receptor activates microglia, immune cells in the brain, but it must be on the cell surface to function correctly. Mutations in TREM2 that alter its location have been implicated in development of Alzheimer's disease (AD) and Parkinson's disease but TREM2 transport within cells remains poorly understood. Researchers led by Huaxi Xu of the Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA, and Qi Wang of the Guangzhou University of Chinese Medicine investigated TREM2 transport by searching for proteins that interact with it. They found that presenilin 1, which has also been implicated in AD, regulates TREM2 transport and affects activation of microglia. These results may help to identify a new target for development of AD treatments.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/emm.2017.200

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 26

Metadata

Authors
Zhao, Y., Li, X., Huang, T., Jiang, L.-L., Tan, Z., Zhang, M., Cheng, I. H.-J., Wang, X., Bu, G., Zhang, Y.-W., Wang, Q., & Xu, H.
Venue
Experimental & Molecular Medicine
Published
2017-12
Volume
49
Issue
12
Pages
e405-e405
ISSN
  • 1226-3613 (ISSN-L)
  • 2092-6413
OpenAlex
W2784174618
Cited by
26
References
31
FWCI
1.23
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.